Improving the odds: Reducing diagnostic uncertainty with bronchoalveolar lavage cytokine profiling. Read more about Improving the odds: Reducing diagnostic uncertainty with bronchoalveolar lavage cytokine profiling.
The transformation of transplant medicine with artificial intelligence-assisted tacrolimus dosing. Read more about The transformation of transplant medicine with artificial intelligence-assisted tacrolimus dosing.
ISHLT consensus statement on the perioperative use of ECLS in lung transplantation: Part II: Intraoperative considerations. Read more about ISHLT consensus statement on the perioperative use of ECLS in lung transplantation: Part II: Intraoperative considerations.
Highly sensitized patients listed for heart after liver transplantation with or without domino. Read more about Highly sensitized patients listed for heart after liver transplantation with or without domino.
Small airway brush gene expression predicts chronic lung allograft dysfunction and mortality. Read more about Small airway brush gene expression predicts chronic lung allograft dysfunction and mortality.
Macrophage and CD8 T cell discordance are associated with acute lung allograft dysfunction progression. Read more about Macrophage and CD8 T cell discordance are associated with acute lung allograft dysfunction progression.
Short airway telomeres are associated with primary graft dysfunction and chronic lung allograft dysfunction. Read more about Short airway telomeres are associated with primary graft dysfunction and chronic lung allograft dysfunction.
Development of the Lung Transplant Frailty Scale (LT-FS). Read more about Development of the Lung Transplant Frailty Scale (LT-FS).
Design and implementation of a digital health home spirometry intervention for remote monitoring of lung transplant function. Read more about Design and implementation of a digital health home spirometry intervention for remote monitoring of lung transplant function.
Immune-Checkpoint Inhibitor (ICI) resumption after severe graft injury in a heart transplant recipient with nivolumab-sensitive metastatic melanoma and renal cell carcinoma. Read more about Immune-Checkpoint Inhibitor (ICI) resumption after severe graft injury in a heart transplant recipient with nivolumab-sensitive metastatic melanoma and renal cell carcinoma.
